APOE and Alzheimer disease: A higher percentage of APOE4 carriers is present in the NT group (48%) than in the DS cohort (15%); however, previous work in the sporadic AD population showed a consistent rate of amyloid accumulation among different AD risk factors, including sex and APOE4 carriage.21